Principal Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $160M | Sell |
|
|||||
|
2025
Q2 | $199M | Sell |
|
|||||
|
2025
Q1 | $190M | Sell |
|
|||||
|
2024
Q4 | $178M | Sell |
|
|||||
|
2024
Q3 | $168M | Buy |
|
|||||
|
2024
Q2 | $146M | Sell |
|
|||||
|
2024
Q1 | $132M | Buy |
|
|||||
|
2023
Q4 | $109M | Buy |
|
|||||
|
2023
Q3 | $98.7M | Buy |
|
|||||
|
2023
Q2 | $99M | Sell |
|
|||||
|
2023
Q1 | $93.8M | Buy |
|
|||||
|
2022
Q4 | $74.8M | Sell |
|
|||||
|
2022
Q3 | $64.2M | Sell |
|
|||||
|
2022
Q2 | $62.9M | Buy |
|
|||||
|
2022
Q1 | $73.5M | Sell |
|
|||||
|
2021
Q4 | $71.1M | Sell |
|
|||||
|
2021
Q3 | $74.2M | Buy |
|
|||||
|
2021
Q2 | $73M | Buy |
|
|||||
|
2021
Q1 | $64.8M | Sell |
|
|||||
|
2020
Q4 | $71.7M | Buy |
|
|||||
|
2020
Q3 | $74.1M | Sell |
|
|||||
|
2020
Q2 | $71.6M | Buy |
|
|||||
|
2020
Q1 | $64.2M | Buy |
|
|||||
|
2019
Q4 | $88.9M | Sell |
|
|||||
|
2019
Q3 | $82.2M | Sell |
|
|||||
|
2019
Q2 | $87.1M | Buy |
|
|||||
|
2019
Q1 | $77M | Sell |
|
|||||
|
2018
Q4 | $71.2M | Sell |
|
|||||
|
2018
Q3 | $78.4M | Buy |
|
|||||
|
2018
Q2 | $65.6M | Buy |
|
|||||
|
2018
Q1 | $54.5M | Sell |
|
|||||
|
2017
Q4 | $49.8M | Buy |
|
|||||
|
2017
Q3 | $57.5M | Sell |
|
|||||
|
2017
Q2 | $56.3M | Buy |
|
|||||
|
2017
Q1 | $49.3M | Buy |
|
|||||
|
2016
Q4 | $42.2M | Sell |
|
|||||
|
2016
Q3 | $48.1M | Buy |
|
|||||
|
2016
Q2 | $45.5M | Sell |
|
|||||
|
2016
Q1 | $36.6M | Buy |
|
|||||
|
2015
Q4 | $35.1M | Buy |
|
|||||
|
2015
Q3 | $30.6M | Sell |
|
|||||
|
2015
Q2 | $33.2M | Buy |
|
|||||
|
2015
Q1 | $32.8M | Sell |
|
|||||
|
2014
Q4 | $24.7M | Sell |
|
|||||
|
2014
Q3 | $60.9M | Buy |
|
|||||
|
2014
Q2 | $23.9M | Buy |
|
|||||
|
2014
Q1 | $24M | Sell |
|
|||||
|
2013
Q4 | $23.3M | Buy |
|
|||||
|
2013
Q3 | $22.6M | Buy |
|
|||||
|
2013
Q2 | $15.1M | Buy |
|